Sort
40,608 grants matching “prostate cancer”
ENHANCEMENT OF VITAMIN D ACTION IN PROSTATE CANCER THROUGH SILENCING OF CYP24
$533,916Baylor College Of Medicine · · FY2008 · Department of Defense
Molecular Mechanisms of Castration Resistant Prostate Cancer Recurrence & Therapeutic Strategies
$533,911Nupam P Mahajan · Washington University · R01 · FY2021 · CA
Getting More from Less: Multi-omic Capture and Analysis from Patient Samples
$533,801Brianna Mullins · Salus Discovery, Llc · R44 · FY2018 · GM
Understanding how T cell intrinsic androgen receptor activity influences cell differentiation and dysfunction
$533,743Amy E Moran · Oregon Health & Science University · R37 · FY2023 · CA
Increasing the diagnostic yield of low-risk bronchial biopsy in the evaluation of
$533,603Melissa J Suter · Massachusetts General Hospital · R01 · FY2015 · CA
Pathology Image Informatics Platform for visualization, analysis and management
$533,529Anant Madabhushi · Case Western Reserve University · U24 · FY2019 · CA
Intimacy-Enhancing Couples' Intervention for Localized Prostate Cancer
$533,526Sharon L Manne · Rbhs -Cancer Institute Of New Jersey · R01 · FY2014 · CA
Mechanisms of Murine Tumor Eradication by Immunotherapy
$533,495Philip D Greenberg · University Of Washington · R01 · FY2011 · CA
A MECHANISTIC STUDY TO EXPLAIN THE SURVIVAL BENEFIT OF CHEMO-HORMONAL THERAPY IN METASTATIC CASTRATION-SENSITIVE PROSTATE CANCER
$533,409Dana-Farber Cancer Institute, Inc. · · FY2016 · Department of Defense
Program in Cancer Outcomes Research Training (PCORT)
$533,397G Scott Gazelle · Massachusetts General Hospital · R25 · FY2008 · CA
MR Guided Focused Ultrasound Surgery for Prostate Cancer
$533,353Clare M Tempany · Brigham And Women'S Hospital · R01 · FY2006 · CA
Prospective Study of Human Oral Microbiome and Pancreatic Cancer Risk
$533,275Jiyoung Ahn · New York University School Of Medicine · R01 · FY2016 · CA
Strategies in therapeutic ultrasound for predicting in situ fields and quantifying the impact of tissue inhomogeneities
$533,014Oleg Sapozhnikov · University Of Washington · R01 · FY2020 · EB
Role of O-GlcNAcome on Breast Cancer Initiating Cells
$532,964Mauricio J. Reginato · Drexel University · U01 · FY2024 · CA
Detection of prostate Cancer Specific Signals with Hybrid Multi-Dimensional MRI
$532,858Aytekin Oto · University Of Chicago · R01 · FY2021 · CA
Preclinical development of a chemopreventive agent, 4-methylumbelliferone(4-MU) HHSN2512015000361 TORFP: 2018-E07 PP: 9/17/18 to 9/16/19
$532,854Clinton Grubbs · University Of Alabama At Birmingham · N01 · FY2018 · CA
Detection of in vivo enzyme activities with CEST MRI
$532,809Mark David Pagel · University Of Arizona · R01 · FY2012 · CA
The protective role of Nrf2 in arsenic-induced toxicity and carcinogenicity
$532,757Donna D Zhang · University Of Arizona · R01 · FY2007 · ES
"Molecular Signatures of Lethal and Indolent Prostate Cancer"
$532,731Mark A. Rubin · Weill Medical Coll Of Cornell Univ · R01 · FY2008 · CA
Descriptive Studies and Record Linkage
$532,689Meredith Shiels · Division Of Cancer Epidemiology And Genetics · ZIA · FY2023 · CA
Mechanisms and therapeutic targeting of lethal prostate cancer master regulator transcription factors
$532,649Josep Maria Domingo-Domenech · Mayo Clinic Rochester · R01 · FY2024 · CA
Mechanisms and therapeutic targeting of lethal prostate cancer master regulator transcription factors
$532,649Josep Maria Domingo-Domenech · Mayo Clinic Rochester · R01 · FY2025 · CA
A Clinical Validation Center for Early Detection of Pancreatic Cancer
$532,530Anirban Maitra · University Of Tx Md Anderson Can Ctr · U01 · FY2021 · CA
AN INTEGRATED GENOMIC DEFINITION AND THERAPEUTIC STRATEGY FOR ANDROGEN-INDIFFERENT PROSTATE CANCERS
$532,526The Univeristy Of Texas M.D. Anderson Cancer Center · · FY2022 · Defense Health Agency
BKV and JCV vaccine development
$532,485Christopher Buck · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA